FASEB Announces 2024 Early-Career Representatives

By: Sybil Walker Barnes
Wednesday, July 24, 2024
To foster dialogue between current and future generations of researchers, FASEB named the 2024–2025 Early-Career Representatives (ECRs) to its Board and Science Policy Committee (SPC):

• Amy Engevik of Medical University of South Carolina
• Kevin Gries of Concordia University of Wisconsin
• Saranya Radhakrishnan of the National Institutes of Health (NIH)
• Matthew Yousefzadeh of Columbia University Medical Center

As voting members of the FASEB Board and SPC, these newly named ECRs will share unique insights and opinions of early-career scientists. They began their two-year terms July 1. 

FASEB Board ECRs
Amy Engevik, PhD, is an assistant professor at the Medical University of South Carolina in the Department of Regenerative Medicine and Cell Biology. She is a member of two FASEB member societies: the American Society for Investigative Pathology and the American Physiological Society, as well as a two-time recipient of the FASEB BioArt Award.

A specialist in aging, Matthew Yousefzadeh, PhD, holds dual appointments as assistant professor of medical sciences at Columbia University Medical Center and a member of the Columbia Center for Translational Immunology. An advocate for early-career researchers, Yousefzadeh also serves as a senior trainee advocate on the Board of Directors for the American Aging Association, a FASEB member society. 

FASEB Science Policy Committee ECRs
Kevin Gries, PhD, is an assistant professor in the Physical Therapy Department at Concordia University of Wisconsin. He is an active member of the American Physiological Society and recently completed a Science Policy Fellowship in the FASEB Office of Public Affairs. His science policy interests lie in enhancing science communication between scientists, government, and the lay community.

Saranya Radhakrishnan, PhD, is a visiting postdoctoral fellow at the NIH’s National Institute of Mental Health (NIMH). Passionate about science policy and advocacy, Radhakrishnan chairs the American Society for Pharmacology and Experimental Therapeutics (ASPET) Young Scientists Committee and participates in the NIH Fellows Committee, Global Mental Health Team at NIMH, and ASPET Animals in Research Science Policy subcommittee. She is participating in FASEB’s SPC in a personal capacity; therefore, her views and contributions do not represent those of NIMH or any U.S. federal government agency.